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Abstract: Until recently, in areas of high malaria transmission such as Nigeria, malaria 
treatment has been based mainly on clinical diagnosis which was presumptive, because 
malaria was considered one of the commonest causes of fever. With the availability of 
new tools such as parasite–based rapid diagnostic kits, a product of biotechnology, 
which complements the standard microscopy, it is imperative to provide targeted 
treatment on accurate estimation of true malaria cases. To proffer solution to the 
limitations of microscopy, this study was carried out to ascertain the reliability of SD 
Bioline HRP-2-Based RDTs in malaria case management. A parasite based diagnosis of 
malaria was carried out on the total 1,276 patients attending an out-clinic in a Semi-
urban area (Amukoko) of Lagos State, South West Nigeria to evaluate specific 
performance characteristics of SD Bioline HRP-2 RDT in malaria case management 
using microscopy as a gold standard. Only 15.4% and 14.6% was positive for P. 
falciparum by HRP- 2-RDT (Rapid Diagnostic Testing) and microscopy respectively 
and the sensitivity, specificity, PPV and NPV are 94%, 98.5%, 91.4% and 98.2% 
respectively. Using RDT, fever has a sensitivity of 79.7% and specificity of 60.5%. 
Patients have fever but no HRP-2 in their blood (fever + Neg. RDT). Since symptoms 
of malaria are not only peculiar to P. falciparum infection, parasite based diagnosis 
must be performed. The performance characteristics of the SD Bioline HRP-2 RDT 
generated from this study indicated that the tool is reliable and fast in generating the test 
result. Similarly, parasite based diagnosis is required to eliminate other causes of fever 
symptoms. 
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Introduction 
Malaria case is defined as a person 
presenting to the clinic with a history 
of fever and concurrent parasitaemia. 
Malaria transmission in Nigeria takes 
place all year round in the south but 
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is more seasonal in the northern 
regions. About 25% of all estimated 
malaria cases in the WHO African 
Region occur in Nigeria [1]. Almost 
all cases are caused by P. 
falciparum, but only a small fraction 
is tested parasite based. Until 
recently, in areas of high malaria 
transmission such as Nigeria, malaria 
treatment has been based mainly on 
clinical diagnosis which was 
presumptive, because malaria was 
considered one of the commonest 
causes of fever. With the availability 
of new tools such as parasite–based 
rapid diagnostic kits, a product of 
biotechnology, which complements 
the standard microscopy, it is 
imperative to provide targeted 
treatment on accurate estimation of 
true malaria cases [2]. However, in 
cases where parasitological 
confirmation is not available, highly 
vulnerable groups (including 
children under five years and those 
suspected with severe malaria) can 
be treated on a clinical basis [2]. 
A new generation of easy to perform 
Rapid Diagnostic Tests (RDTs) has 
been developed to diagnose P. 
falciparum rapidly and reliably 
without the need of a microscope. 
This is based on the 
immunochromatographic detection 
of antigen histidine–rich protein II 
(HRP-2) or specific plasmodium 
lactate dehydrogenase (pLDH). Both 
HRP-2 and pLDH are produced by 
the parasite during their growth and 
multiplication in red cells. In 
Nigeria, Parasight TML ICT and 
OptiMAL became commercially 
available in 2000. More recently, 
others like SD Bioline were also 
introduced into the Nigerian market. 
Studies to evaluate the efficacy of 
these RDTs in Nigeria [3-5], have 
reported efficacy similar to expert 
microscopy. 
In addition, RDTs have been shown 
to be cost effective in malaria case 
management in Nigeria [6] and 
potentially saves the cost and time 
wasted on presumptive treatment [3]. 
This of course is essential in 
effective malaria case management, 
which entails early diagnosis and 
prompt treatment with effective 
antimalarial medicines recommended 
for use in the Country. 
Unfortunately, this has received a 
major setback in the past years 
because of the high level of 
resistance to the first and second line 
antimalarial medicines; Chloroquine 
and Sulphadoxine–pyrimethamine 
[2]. Despite the observed changes in 
parasite sensitivity to artemisinins, 
the clinical and parasitological 
efficacy of artemisinin based 
combination therapies (ACTs) has 
not yet been compromised [7], until 
recently when the drug efficacy 
studies have detected resistance of 
Plasmodium falciparum to 
artemisinins in the South-East Asia. 
P. falciparum resistance to 
artemisinins has not been detected 
outside of the Greater Mekong sub-
region [8]. 
Perceived fever is the sign most 
health workers use to diagnose 
clinical malaria. However, studies in 
areas of intense transmission have 
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found reported fever or a history of 
fever to be an unreliable indicator of 
clinical malaria. It is reported that 
clinical diagnosis of malaria has led 
to over–diagnosis and over–
consumption of anti-malarial since 
malaria presentation is not specific 
[9-10] and have, therefore, not been 
helpful in improving malaria 
diagnosis. Hence, prompt 
parasitological confirmation by 
microscopy or with RDT is 
recommended for all patients with 
suspected malaria before treatment is 
started [7]. In addition, treatment 
solely on clinical suspicion should 
only be considered when a 
parasitological diagnosis is not 
accessible [2]. This then took us into 
the study of SD Bioline HRP-2-
Based RDTs in malaria case 
management. 
The objective of this work is thus: 
(a) To validate the SD-Bioline HRP-
2-based RDT diagnostic 
performance using microscopy as a 
standard. 
(b) To ascertain the performance 
characteristics of clinical diagnosis 
using SD–Bioline HRP– 2–Based 
RDTs as a standard in malaria case 
management. 
Materials and Methods 
Study Area: The study site was at St. 
Matthew Primary Health Care 
Centre, situated at No. 3 Mayegun–
Oro St., Amukoko in Ajiromi–
Ifelodun Local Government Area, on 
the Longitude 6027’ 52”N and 
Latitude 3020’44” E. It is 14 km 
from Lagos center. It is bounded on 
the North by Apapa Local 
Government Area and on the East by 
Amuwo–Odofin Local Government 
Area. Amukoko is one of the 50 
communities found in Ajeromi–
Ifelodun LGA of Lagos state and it is 
densely populated with population 
density of 687,316 (Nigeria Census, 
2006). The laboratory work was 
carried out at The International 
Center for Malaria Microscopy and 
Malaria Rapid Diagnostic Tests 
Quality Assurance Programme, 
Department of Medical 
Microbiology and Parasitology, 
College of Medicine University of 
Lagos (CMUL), Idi–Araba. The 
“Standard for reporting diagnostic 
accuracy recommendations” was 
followed [11]. 
Ethical approval for this study was 
obtained from the Ethics Committee 
of the College of Medicine of the 
University of Lagos and Lagos 
University Teaching Hospital, 
Lagos, Nigeria. 
Study Procedures 
Participants were administered with 
the consent form and the intending 
patients were given case report form 
(CRF) for any history of febrile 
illness or malaria, anti malaria 
treatment in the past 2 weeks, taking 
temperature with mercury 
thermometer (Goshen CE 0483,), age 
and other relevant data were also 
recorded (Appendix A & B). 
Samples were collected from 
individuals of all ages from infants to 
the old who attended St. Matthew 
Primary Health Care Center. 
Venous blood of 5ml was collected 
from peripheral vein of each 
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participant and shared into EDTA 
and plain bottles. The EDTA blood 
was diluted in the ratio 1:20 against 
turk solution for WBC count using 
“Neubauer ruled chamber 
(Germany(R)) and recorded. 
Study Sample: The criteria for 
inclusion included the complaints of 
fever and malaise at the time of 
survey or in the past 48 hours and 
other malaria related symptoms like 
headache, body weakness, chills, 
joint pains, diarrhoea, cough and 
vomiting. Patients on admission 
were excluded from the research. 
The study area is a rural settlement 
composed of artisans and traders that 
deal in trade ranging from Carpentry 
& Upholstery, Transportation to Site 
labour. 
A total of 1,276 subjects, which 
cover all age groups, were selected 
for this study using random sampling 
method of the patient attending 
outpatient department (OPD) of the 
primary health center. The 
recruitment was based on the 
presentation of symptoms and 
previous clinical history as narrated 
by the patient. It was a prospective 
study in which data collection was 
done before reference standard were 
performed. 
The patients’ whole blood was 
collected by vein puncture to test for 
the presence of P. falciparum 
malaria antigen (HRP-2) and for 
microscopic identification. 
Description and Interpretation of 
MRDTs 
The procedure of the test was strictly 
adhered to according to 
manufacturer’s instructions. 
Standard Diagnostic Bioline HRP-
2 Based RDT: The test device had a 
LOT number 082048 and an expiry 
date of 31st March 2012. Quality 
assurance testing was carried out on 
the RDTs used for the test by “The 
International Center for Malaria 
Microscopy and Malaria Rapid 
Diagnostic Tests Quality Assurance 
Programme. Department of Medical 
Microbiology and Parasitology, 
CMUL, Idi–Araba”, before use. The 
device was seen to contain a cassette, 
an applicator loop stick, lancet, a 
buffer solution and desiccant. The 
cassette had two wells on the surface 
as shown in Picture 2. The labeling 
was done on the RDT cassette using 
glass marker and placed on a smooth 
flat dry surface. 5μl of blood (one 
loop-full) was added to the smaller 
sample well on the cassette with the 
aid of the applicator loop stick, 4 
drops of the buffer was added into 
the second sample well, which is 
larger. As the test began to work, a 
pinkish–red color was seen moving 
across the result window in the 
center of the test device. Test result 
was interpreted within 15 minutes. 
A RDT result was interpreted as 
positive when both the test line and 
control line showed pink (Picture 3), 
negative when only the control line 
showed pink or invalid when the 
control line did not appear regardless 
of the test line (Picture 4). Four 
independent readings were graded 
based on visual assessment as "3+ or 
high" if the test line is darker than 
the control, " 2+ or moderate” if the 
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test line was as intense as the control 
line, “1+ or light” if the result was a 
line that could only be seen in good 
light for reactive tests and " – or 
negative" for non-reactive ones, 
where no line is seen but for the 
control. 
Grading was also used to determine 
the source of variability in results 
reported by two independent readers. 
Any invalid RDT test was repeated. 
Two scientists read RDT cassettes 
independently. Temperature and 
humidity for the storage conditions 
for RDTs during study period were 
maintained. 
Microscopy: This entails film 
preparation, staining process, and 
mounting of the slide on the stage as 
well as counting and identification. 
Malaria Blood Film (MBF) 
Preparation 
Two (2) malaria blood films (MBF) 
were prepared for each patient, one 
is marked “R” for “read” and “A” for 
“archive” on the glass slide. On the 
frosted end of the grease free slides, 
the identification number and date 
for each participant were written 
using a glassmaker. A 12 μl of blood 
was spread over a diameter of 15 
mm for a thick blood film while 2 μl 
of blood was used for a thin blood 
film on the same slide. Another clean 
slide was used to spread the blood 
drops to get a thin film by placing at 
an angle of 450 at the edge of the 
blood drop and then pulled forward 
to make an even spread with a tail 
end. The thin film was fixed in 
absolute methanol for 2 seconds to 
prevent lysis of the red blood cells 
and air dried on the rack [12]. The 
dried slides were kept in the 
incubator already set at 350C for 48 
hours, EDTA blood took longer time 
to dry. 
The blood films were stained after 48 
hours with 3% Giemsa stain solution 
at pH 7.2. The stain was left for 45 
minutes and then gently rinsed off 
with buffered solution of pH 7.2 
until the flooding became clear to 
sight [12]. The slides were then 
placed vertically in a slide rack and 
allowed to dry and later arranged 
into the slide box. 
Microscopic examinations of stained 
blood films were done using X100 
oil immersion objectives. A 
minimum of 100 fields was carefully 
examined horizontally down on the 
thick film to ascertain the slide 
negative for malaria parasites. A 
definitive diagnosis of malaria by 
microscopy was made when a 
reddish chromatin dot with a purple 
or blue cytoplasm of the malaria 
parasites are seen together. 
Malaria parasites seen on the slides 
were counted against 200 WBC or 
500 if the parasite count is less than 
100 parasites/200 WBC. The number 
of asexual parasitic forms 
(trophozoites and schizonts) and 
sexual (gametocytes) present in these 
microscopic fields was recorded 
separately. The slides were adjusted 
to read the thin film for parasite 
identification, concentration and 
clarity was observed at the tail end of 
the film. The calculation of the total 
number of parasite/μl of blood 
required the input of total white 
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blood cell (WBC) count and the 
formula is computed as: 
The stained slides were read by 
myself and a competent microscopist 
as Reader-1 and Reader- 2. The 
parasite density was calculated for 
each of the reader and the mean 
parasite density was obtained from 
the two readers by adding the two 
parasite density and divided by 2. 
Microscopy was considered the gold 
standard reference level for positivity 
or negativity for the RDT device and 
SD Bioline HRP –2–Based RDT as 
the standard for the clinical 
symptoms. The age grouping was 
done to the nearest whole number, 
no gap is included nor any group 
excluded. All data were entered and 
analyzed using Statistical Package 
for Social Sciences for Windows V 
17 (SPSS Inc., Chicago, IL). The 
comparism was done at 95% 
confidence intervals. 
 
Performance Characteristics 
The sensitivity, specificity, PPV, 
NPV and test efficiency of clinical 
symptoms was calculated using 1273 
whole–blood samples and SD-
Bioline HRP-2 RDT as the reference 
test. The formula is as follows [13]. 
Sensitivity was calculated as: 
 
 
Picture 2: The pictorial view of the  
labelled SD Bioline HRP-2 RDT cassette.  
(T, test window; C, control window; A, 
sample well; and B, buffer well) 
 
Picture 3: The RDT cassette with the  
result Lines 
 
 
Picture 4: The pictorial view of the 
cassette indicating the test result after 15 
minutes of applying the sample. 
 
Results 
This research was done between the 
month of November 2010 and 
August, 2011. The demographic 
characteristics of the study 
participants are shown in Table 1. A 
total of 1,276 people were included 
in the analysis, which is composed of 
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60.2% female, and the overall mean 
age was 26.30 years with the range 
from 0.083 to 80 years. 
Table 1. The malaria parasite 
prevalence by blood slide 
microscopy was 14.6% (186/1273) 
and 15.4 % (197/1273) by SD 
Bioline HRP-2-Based RDT. This put 
the HRP-2 RDT to the sensitivity 
value of 94%, specificity value of 
98.5%, PPV of 91.4% and NPV of 
98.2%. The older children age group 
“6-11years” presented the highest 
prevalence of 19.3% followed by 
adolescent by children ≤5 years with 
13.7% (Table I). 
Table 2. The distribution of 
symptoms with respect to age is 
represented on Table 2, fever is 
higher in children ≤ 5years (11.1%) 
than in older children “6–11” (6.8%) 
and in adolescent “12–16” (3.2%). 
Also high in the younger children ≤5 
are chills, headache and febrile fever 
compared to older children and 
adolescent. The rate of vomiting is 
the same in the younger children and 
older children (19.6%) than in the 
other age groups. Adolescent 
presented the highest rate of loss of 
appetite (17.6%) but lowest in the 
adult group age “17 years and 
above”. Adult group presented more 
diarrhoea than adolescent, followed 
by children ≤5years, older children 
have no diarrhoea. Children ≤5 years 
rated highest for cough (21.8%) 
followed by adult (14.3%), 
adolescent (13.4%) and older 
children (12.5%). Sleeplessness and 
dizziness are for adult while older 
children “6–11 years” presented 
highest level of yellow urine (51.8%) 
followed by adult (47.6%), 
adolescent has 41.8% and children 
≤5 years have 39.7%. Diagnosing 
with febrile fever (tempt. ≥37.50C) 
gave 18.1% prevalence and fever 
complaints by the patient rated 
highest even among other symptoms 
at 63.5%. Only 12 patients had had 
convulsion before attending the 
health center and are found negative 
by RDT. 18.3% of total male and 
13.5% of total female were positive 
for HRP-2. There is statistical 
significant difference between the 
age and infection (P<0.05). 
The relationship between various 
symptoms and infection using RDT 
and microscopy are also captured on 
Table 3. 
Table 3. There was no much 
difference in the percentage 
occurrence of the symptoms in the 
two diagnostic methods. It is 
observed that 79.7% of the patients 
was having HRP-2 in their peripheral 
blood and presenting fever at the 
same time (Pos RDT + Fever) which 
is higher than (Pos. microscopy + 
fever) at 74.7%. So also (Neg. RDT 
+ No fever) at 25.3% is higher than 
(Neg. microscopy + No fever) at 
20.3%. (Pos. microscopy + joint 
ache) at 46.2% is higher than (Pos. 
RDT + Joint ache) at 40%. (Fever + 
Neg. RDT) was at 60.5%. 
45.8% of the patients recruited for 
this study had access to medicines. 
Of the total 584 patients having 
access to medicine (ATM), 52% had 
taken herbal remedy “Agbo”, 43% 
took paracetamol/pain reliever 
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(PCM) and 36% took ACT. The drug chart is represented in Fig. 1 and 2.
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Discussion  
The prevalence of malaria from this 
study is 15.4% with a highly 
sensitive SD Bioline HRP-2- Based 
RDT (sensitivity= 94%, 
specificity=98.5%, PPV=91.4% and 
NPV=98.2) when compared with the  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
gold standard microscopy. 
 This result is consistent with other 
published studies showing that the 
sensitivity and specificity of HRP-2-
based tests usually are > 90% for P. 
falciparum [14-15].  
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Comparing the two diagnostic 
methods, prevalence by RDT is 
higher than microscopy. This is 
contrary to the report by [16}, where 
the prevalence of malaria parasites 
by slide microscopy was higher than 
prevalence by RDT though the 
different was not statistically 
significant. This is further confirmed 
in reports by [17] that RDTs have 
shown a comparable level of 
accuracy to microscopy in clinical 
setting. This is not surprising as the 
quality assurance studies have been 
conducted on all the RDTs used for 
this research work by “The 
International Center for Malaria 
Microscopy and Malaria Rapid 
Diagnostic Tests Quality Assurance 
Programme, Department of Medical 
Microbiology and Parasitology, 
College of Medicine University of 
Lagos, Idi–Araba”. 
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Fig. 1 (Right): Chart 
indicating percentage patient and disposition to drug before attending Clinic (CQ-chloroquin; 
SP-sulphadoxine pyrimethamine, ACT-artemisinin-based combination therapy; ATB-antibiotics; AGBO-herbal remedy 
for malaria; PCM-paracetamol  
 
 
Fig. 2: The percentage of drug taken by those having access to medicine only 
 
The prevalence of malaria in this 
study contrast sharply with the 
prevalence reported in the North 
Western Nigeria of prevalence rate 
of 27.29% [18], this is attributed to 
the fact that most of the sampling 
collection was done in the early part 
of the year when the transmission is 
usually low due to dry season period 
of the year. 
Children are still more vulnerable, 
but there is now a shift from the ≤5 
years which was at 16% in Nigeria 
as reported in the World Malaria 
Report [7] to 19.3% of the older 
children of age group “6-11years” as 
observed from this study. The drop 
in the prevalence is not surprising 
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because of the various intervention 
strategies adopted for the Country in 
the last one decade that focuses on 
all age group in the country which 
include the disbursement of 
insecticide treated nets/ long lasting 
insecticide nets (ITNs/LLINs) in 
2009 [1]. 
The prevalence is observed to be 
higher by RDTs than microscopy 
basically due to the fact that some 
patients are fond of self-medication 
as indicated in the case report form 
(CRF). Some of the patients had 
taken anti-malaria, which has the 
ability to bring down the level of 
parasitaemia, but P. falciparum 
antigens HRP-2 still persist in the 
peripheral blood. In Fig. 1, 45.8% of 
the patients had access to drug, 
31.4% actually kept the medicine at 
home. 16.3% had taken 
ACT and 23.9% had taken “Agbo” 
before coming to the clinic. From 
Fig. 2, 52% of those having access to 
medicine had taken herbal remedy 
“Agbo” before attending the clinic 
while 32% had actually taken 
artemisinin based combination 
therapies (ACTs). Among many 
plants used for herbal remedy 
“Agbo” for malaria are lemon grass, 
bitter leaf, brimstone leaf, pawpaw 
leaf and mango tree bark which have 
been proved effective (Adodo, 
2008), this is the reason for low or 
no parasitaemia compared to HRP-2 
positive. 
There was no statistical significant 
different between the symptoms and 
age (Table 2) except for Nausea and 
Diarrhoea (p<0.05). From this study, 
it can be said that 157 (79.7%) of the 
total patients having HRP-2 in their 
peripheral blood and presenting fever 
are actually regarded as having 
malaria case, this is higher than what 
is observed with microscopy 139 
(74.4%), 653 (60.5%) patients have 
fever but no HRP- 2 in their blood 
(fever + Neg. RDT) as represented 
on Table 4, meaning there are other 
aetiologies of fever other than P. 
falciparum which may include 
influenza, shigella, salmonella, 
cholera etc, which could have been 
the causative agents in these negative 
results. This is therefore in 
agreement with the report of a work 
done in a similar endemic region that 
stated that clinical diagnosis has little 
utility in malaria case management 
[19]. 
18.1% prevalence by febrile fever 
(tempt. ≥37.50C) is lower compared 
to the findings reported by [20] in 
Senegal at 49.7% though theirs was 
calculated from 380C and above. The 
fever complaints in this study were 
63.5%, which is also lower, 
compared to 80.4% found in 
Senegal. The twelve (12) patients 
that had had convulsion before 
attending the health center were 
cleared from malaria by presenting a 
negative RDT result. The severe 
presentation of convulsion may be 
because of the poor ventilation of the 
residence houses of the patients. 
Based on the high sensitivity coupled 
with the rapid availability of the test 
result which is practicable in twenty 
(20) minutes, SD Bioline HRP-2-
Based RDT is hereby preferred to 
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microscopy this is in line with the 
requirements documented by [21] 
which also include technical 
simplicity of the test and training 
needs, ease of interpretation and 
absence of any need for electricity to 
operate the assay. Further criteria 
essential for selecting appropriate 
RDTs by an operational manual on 
universal access to malaria 
diagnostic testing [22] are the 
supplier’s production capacity and 
lead times, storage conditions, 
delivery schedules, shelf-life as well 
as registration and budget 
requirements. With the availability 
of the quality assured sole 
distributors in Nigeria such as Codix 
Pharma Ltd. and others, SD Bioline 
HRP-2-Based RDTs should be 
advocated for use in every level of 
health care facilities. 
Conclusion 
The performance characteristics of 
the SD Bioline HRP-2 RDT gotten 
from this study indicated that it is 
reliable in the parasite based 
diagnosis of malaria, but clinical 
symptoms are not reliable yet, the 
parasite based diagnosis must always 
be done to eliminate other causes of 
the symptoms. Based on the high 
sensitivity coupled with the rapid 
availability of the test result which is 
practicable in twenty (20) minutes 
from this study, SD Bioline HRP-2-
Based RDT is hereby preferred to 
microscopy. The low prevalence rate 
from this study indicated the effect 
of the intervention put in place by 
the national malaria control 
programme (NMCP). 
With the availability of the quality 
assured distributors of SD Bioline 
HRP-2-Based RDTs in Nigeria like 
Codix Pharma Ltd. and others, I 
hereby recommend that the 
continuous effort by national and 
international organization on the 
malaria control should be 
strengthened with a continuous 
advocate for the use of HRP-2-Based 
RDT in the malaria case 
management for all level of health 
facilities, so that Nigeria can also be 
enlisted one day with malaria-free 
Countries. 
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